Nancy Schimelpfening

Freelance Health Writer/Editor

san antonio, texas, united states

Publications:

About

I am seeking employment as a writer and/or editor of online content. I have 28 years of experience as a writer and five years of experience as an editor. In addition, I have a B.S. degree in biology and an M.S. degree in community health education.

Featured Articles

Ozempic, Wegovy: GLP-1 Drugs Lower Breast Cancer Risk by 30%

- A new study found that females using GLP-1 drugs had about a 30% lower risk of developing breast cancer. - The effect may be related to the metabolic improvements associated with this class of medications. - More research is needed before GLP-1 drugs ca... See more

healthline.com•Nancy Schimelpfening•Jun 3, 2026

Antidepressants Safe During Pregnancy, Not Linked to Autism, ADHD

- A comprehensive review found no causal link between antidepressant use before or during pregnancy and ADHD or autism. - Any association of neurodevelopmental disorders appears to be linked to genetic or environmental factors. - While antidepressants do ... See more

healthline.com•Nancy Schimelpfening•May 15, 2026

New Zepbound-Like GLP-1 Drug Leads to 16% More Weight Loss

- A new weight loss drug called survodutide has shown promising results in a phase 3 clinical trial. - The drug, which stimulates GLP-1 and glucagon receptors, led to a 16.6% drop in body weight. - Survodutide also reduced waist circumference, an indicato... See more

healthline.com•Nancy Schimelpfening•May 4, 2026

Cardiovascular Disease: New Guidance Says 9 Key Steps Can Reduce Risk

- The AHA has released updated dietary guidance to reduce the risk of heart disease. - The new guidelines focus on flexibility and accessibility, no matter where you are. - They include nine essential features of a heart-healthy dietary pattern. - Experts... See more

healthline.com•Nancy Schimelpfening•Apr 2, 2026

Women Who Exercise Cut Their Risk of Early Death in Half

- A new study reports that midlife exercise can cut women’s risk of early death in half. - Women tend to lose muscle mass starting in midlife, which can affect health, but adequate exercise and sufficient protein intake can help preserve muscle mass. - Th... See more

healthline.com•Nancy Schimelpfening•Mar 31, 2026

HARO Queries

AI used to develop vaccine that protects against multiple viruses

Health and Pharma

Deadline: Jun 11th, 2026 1:00 AM ET

•

Healthline

•

6 responses

Oncologist:Study suggests Prosigna can ID who can use hormone therapy alone

Health and Pharma

Deadline: Jun 8th, 2026 10:00 AM ET

•

Healthgrades

•

3 responses

Oncologist: GLP-1 use associated with reduced breast cancer incidence

Health and Pharma

Deadline: Jun 3rd, 2026 10:00 AM ET

•

Healthline

•

11 responses

Obesity: "Strong reponse endotype" benefits most from tirzepatide for OSA

Health and Pharma

Deadline: May 29th, 2026 10:00 AM ET

•

Healthgrades

•

11 responses

Breast cancer that has spread controlled longer with targeted radiotherapy

Health and Pharma

Deadline: May 22nd, 2026 10:00 AM ET

•

Healthgrades

•

5 responses

HARO Queries

Social Media

Pitching Guidelines

No guidelines added yet. Add your pitching preferences to help sources craft the perfect outreach.

Pitching Guidelines

Quick Stats

Followers

172

Articles42

Last Article11 days ago

Stats

Education

Doctor Of Education, Education, Public Health at American College Of EducationExpected Graduation: 2029

Masters, Health Education at Old Dominion UniversityGraduated: 1997

Bachelors, Biology at University Of CharlestonGraduated: 1989

Education

Contact

Connect with journalists.

HARO Queries

AI used to develop vaccine that protects against multiple viruses

Health and Pharma

Deadline: Jun 11th, 2026 1:00 AM ET

•

Healthline

•

6 responses

Oncologist:Study suggests Prosigna can ID who can use hormone therapy alone

Health and Pharma

Deadline: Jun 8th, 2026 10:00 AM ET

•

Healthgrades

•

3 responses

Oncologist: GLP-1 use associated with reduced breast cancer incidence

Health and Pharma

Deadline: Jun 3rd, 2026 10:00 AM ET

•

Healthline

•

11 responses

Obesity: "Strong reponse endotype" benefits most from tirzepatide for OSA

Health and Pharma

Deadline: May 29th, 2026 10:00 AM ET

•

Healthgrades

•

11 responses

Breast cancer that has spread controlled longer with targeted radiotherapy

Health and Pharma

Deadline: May 22nd, 2026 10:00 AM ET

•

Healthgrades

•

5 responses

Nancy Schimelpfening

About

Featured Articles

Ozempic, Wegovy: GLP-1 Drugs Lower Breast Cancer Risk by 30%

Antidepressants Safe During Pregnancy, Not Linked to Autism, ADHD

New Zepbound-Like GLP-1 Drug Leads to 16% More Weight Loss

Cardiovascular Disease: New Guidance Says 9 Key Steps Can Reduce Risk

Women Who Exercise Cut Their Risk of Early Death in Half

HARO Queries

AI used to develop vaccine that protects against multiple viruses

Oncologist:Study suggests Prosigna can ID who can use hormone therapy alone

Oncologist: GLP-1 use associated with reduced breast cancer incidence

Obesity: "Strong reponse endotype" benefits most from tirzepatide for OSA

Breast cancer that has spread controlled longer with targeted radiotherapy

Social Media

Education

Contact

Contact Details

Connect with journalists.

Connect with journalists.

Social Media

Contact

Contact Details

Education

Featured Articles

Ozempic, Wegovy: GLP-1 Drugs Lower Breast Cancer Risk by 30%

Antidepressants Safe During Pregnancy, Not Linked to Autism, ADHD

New Zepbound-Like GLP-1 Drug Leads to 16% More Weight Loss

Cardiovascular Disease: New Guidance Says 9 Key Steps Can Reduce Risk

Women Who Exercise Cut Their Risk of Early Death in Half

HARO Queries

AI used to develop vaccine that protects against multiple viruses

Oncologist:Study suggests Prosigna can ID who can use hormone therapy alone

Oncologist: GLP-1 use associated with reduced breast cancer incidence

Obesity: "Strong reponse endotype" benefits most from tirzepatide for OSA

Breast cancer that has spread controlled longer with targeted radiotherapy